Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC)

151 filings reported holding FULC - Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2025.
Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 53.8M shares of 54M outstanding shares and own 99.5% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (10.2M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (5.38M shares), TCG Crossover Management, LLC (5.25M shares), Nantahala Capital Management, LLC (4.67M shares), BlackRock, Inc. (3.71M shares), VANGUARD GROUP INC (3M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.43M shares), Balyasny Asset Management L.P. (1.45M shares), D. E. Shaw & Co., Inc. (1.45M shares), and DIMENSIONAL FUND ADVISORS LP (1.3M shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.